Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
WallStreetSelect 114
WallStreetSelect 114
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
Clearmind Medicine Inc. - Common Shares
(NQ:
CMND
)
2.340
-0.020 (-0.85%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Jul 6, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
28,976
Open
2.280
Bid (Size)
2.280 (200)
Ask (Size)
2.350 (200)
Prev. Close
2.360
Today's Range
2.222 - 2.350
52wk Range
2.040 - 524.00
Shares Outstanding
N/A
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Clearmind Medicine Advances Its Innovation with Newly Granted U.S. Patent, Enhancing Global Patent Strength
June 29, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Reaches Major Milestone, Completing Part A Treatment in FDA‑Regulated Phase I/II Trial
June 22, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Performance
YTD
-88.2%
-88.2%
1 Month
-41.2%
-41.2%
3 Month
-80.0%
-80.0%
6 Month
-90.6%
-90.6%
1 Year
-99.4%
-99.4%
More News
Read More
Clearmind Medicine Granted U.S. Patent for Binge Behavior Regulators
June 18, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Completes Dosing for Part A of its of FDA-Regulated Phase I/II Clinical Trial
June 16, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Monday's pre-market session: top gainers and losers
↗
June 08, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
June 05, 2026
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
June 05, 2026
Via
Chartmill
Clearmind Medicine to Feature New Insights from CMND-100 Psychedelic Clinical Trial on “Inside MEAI” Webinar
June 05, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Stocks to Watch: ANY, CMND, PRFX, OLOX, IGC Data Centers, AI, Quantum & Healthcare
June 03, 2026
Via
AB Newswire
Topics
Artificial Intelligence
Energy
Intellectual Property
Monday's session: gap up and gap down stocks
↗
June 01, 2026
Via
Chartmill
Top stock movements in today's session.
↗
May 29, 2026
Via
Chartmill
Friday's session: gap up and gap down stocks
↗
May 29, 2026
Via
Chartmill
Clearmind Medicine Advances Global Intellectual Property Portfolio with Japanese Patent Filing for Innovative Psychedelic- Based Depression Treatment
May 29, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Johns Hopkins IRB Approval to Advance CMND-100 Phase I/II Clinical Trial to the Next Parts
May 26, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
What's going on in today's session
↗
May 19, 2026
Via
Chartmill
Let's take a look at the stocks that are in motion in today's session.
↗
May 19, 2026
Via
Chartmill
There are notable gap-ups and gap-downs in today's session.
↗
May 19, 2026
Via
Chartmill
Wondering what's happening in today's pre-market session?
↗
May 19, 2026
Via
Chartmill
Clearmind Medicine Announces 1-for-10 Reverse Share Split
May 19, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Signs Agreement to Examine MEAI in Combination and Sequencing with Tirzepatide Against Blockbuster GLP-1 Medications
May 18, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine CEO Dr. Adi Zuloff-Shani named Delegate to Federal Policy Summit on Psychedelic Medicine in Washington, D.C.
May 15, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Reaches Important Clinical Milestone: 20 Participants Now Treated in Ongoing Phase I/IIa Trial of CMND-100 for Alcohol Use Disorder
May 12, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces “Inside MEAI” Webinar Featuring New Insights from CMND-100 Psychedelic Clinical Trial
May 11, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Filing of European Patent Application for Novel Psychedelic Compounds for the Treatment of PTSD
May 05, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Clearmind Medicine Announces Evaluation of its Psychedelic-Based Treatment (MEAI) for Potential FDA Breakthrough Therapy Designation
April 27, 2026
From
Clearmind Medicine Inc.
Via
GlobeNewswire
Frequently Asked Questions
Is Clearmind Medicine Inc. - Common Shares publicly traded?
Yes, Clearmind Medicine Inc. - Common Shares is publicly traded.
What exchange does Clearmind Medicine Inc. - Common Shares trade on?
Clearmind Medicine Inc. - Common Shares trades on the Nasdaq Stock Market
What is the ticker symbol for Clearmind Medicine Inc. - Common Shares?
The ticker symbol for Clearmind Medicine Inc. - Common Shares is CMND on the Nasdaq Stock Market
What is the current price of Clearmind Medicine Inc. - Common Shares?
The current price of Clearmind Medicine Inc. - Common Shares is 2.340
When was Clearmind Medicine Inc. - Common Shares last traded?
The last trade of Clearmind Medicine Inc. - Common Shares was at 07/06/26 04:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.
